| Lastest Insider Transactions Of Royalty Pharma plc ( RPRX ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| RPRX | Royalty Pharma plc | Hite Christopher | EVP & Chairman, Partnering | 2026-08-18 | Sell | 100,000 | 59.97 | 5,997,250 | 2026-08-19 16:20:53 |
| RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | 2026-08-13 | Sell | 11,002 | 58.68 | 645,551 | 2026-08-17 17:01:12 |
| RPRX | Royalty Pharma plc | Hite Christopher | EVP & Chairman, Partnering | 2026-06-30 | Sell | 130,000 | 56.50 | 7,345,471 | 2026-07-02 16:08:32 |
| RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | 2026-06-24 | Sell | 9,098 | 55.18 | 502,067 | 2026-06-25 17:13:55 |
| RPRX | Royalty Pharma plc | Hite Christopher | EVP & Chairman, Partnering | 2026-06-23 | Sell | 150,000 | 54.40 | 8,159,277 | 2026-06-25 17:11:53 |
| RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | 2026-05-26 | Sell | 64,399 | 53.98 | 3,476,116 | 2026-05-28 16:48:21 |
| RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | 2026-05-20 | Sell | 13,684 | 52.75 | 721,838 | 2026-05-21 21:20:12 |
| RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | 2026-05-14 | Sell | 13,684 | 53.06 | 726,137 | 2026-05-15 16:38:40 |
| RPRX | Royalty Pharma plc | Norden Gregory | Directior | 2026-05-14 | Sell | 3,045 | 53.00 | 161,385 | 2026-05-15 16:37:04 |
| RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | 2026-04-28 | Sell | 34,791 | 49.78 | 1,731,840 | 2026-04-30 17:54:06 |
| RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | 2026-04-01 | Sell | 34,791 | 48.33 | 1,681,512 | 2026-04-02 17:58:57 |
| RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | 2026-03-23 | Sell | 34,791 | 45.53 | 1,583,989 | 2026-03-25 17:05:22 |
| RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | 2026-03-02 | Sell | 34,791 | 46.78 | 1,627,534 | 2026-03-04 17:11:47 |
| RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | 2026-02-23 | Sell | 34,791 | 45.32 | 1,576,606 | 2026-02-25 16:08:28 |
| RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | 2026-02-02 | Sell | 243,541 | 42.54 | 10,360,814 | 2026-02-04 17:07:40 |
| RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | 2026-01-30 | Sell | 20,000 | 41.09 | 821,810 | 2026-02-02 16:59:30 |
| RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | 2026-01-23 | Sell | 20,000 | 40.26 | 805,110 | 2026-01-26 16:10:58 |
| RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | 2026-01-20 | Sell | 69,582 | 39.35 | 2,737,940 | 2026-01-23 16:48:33 |
| RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | 2026-01-16 | Sell | 20,000 | 39.52 | 790,346 | 2026-01-20 17:00:25 |
| RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | 2026-01-09 | Sell | 20,000 | 40.78 | 815,634 | 2026-01-13 17:37:44 |
| RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | 2026-01-02 | Sell | 69,582 | 38.42 | 2,673,041 | 2026-01-06 16:18:43 |
| RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | 2026-01-02 | Sell | 20,000 | 38.48 | 769,650 | 2026-01-06 16:17:52 |
| RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | 2025-12-26 | Sell | 20,000 | 39.32 | 786,380 | 2025-12-29 16:58:27 |
| RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | 2025-12-19 | Sell | 20,000 | 38.38 | 767,582 | 2025-12-22 16:09:42 |
| RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & CLO | 2025-12-17 | Sell | 110,000 | 38.55 | 4,240,334 | 2025-12-19 17:24:49 |
| RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | 2025-12-16 | Sell | 20,000 | 38.32 | 766,420 | 2025-12-17 17:43:16 |
| RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | 2025-12-16 | Sell | 20,000 | 38.32 | 766,420 | 2025-12-17 17:43:16 |
| RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | 2025-12-15 | Sell | 69,582 | 38.36 | 2,669,173 | 2025-12-17 17:39:45 |
| RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | 2025-12-05 | Sell | 41,576 | 39.15 | 1,627,815 | 2025-12-09 17:00:36 |
| RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & CLO | 2025-12-03 | Sell | 110,000 | 39.77 | 4,375,008 | 2025-12-05 17:01:28 |
| RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | 2025-12-01 | Sell | 69,582 | 39.87 | 2,773,956 | 2025-12-03 17:11:18 |
| RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | 2025-12-01 | Sell | 69,582 | 39.87 | 2,773,956 | 2025-12-03 17:11:18 |
| RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | 2025-12-01 | Sell | 41,575 | 39.92 | 1,659,489 | 2025-12-03 17:10:29 |
| RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | 2025-12-01 | Sell | 41,575 | 39.92 | 1,659,489 | 2025-12-03 17:10:29 |
| RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | 2025-11-24 | Sell | 69,582 | 38.55 | 2,682,506 | 2025-11-26 17:01:45 |
| RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | 2025-11-24 | Sell | 69,582 | 38.55 | 2,682,506 | 2025-11-26 17:01:45 |
| RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & CLO | 2025-11-19 | Sell | 135,426 | 38.34 | 5,192,656 | 2025-11-21 16:55:37 |
| RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | 2025-11-17 | Sell | 69,594 | 39.30 | 2,735,329 | 2025-11-19 16:53:33 |
| RPRX | Royalty Pharma plc | Norden Gregory | Directior | 2025-08-08 | Sell | 33,500 | 36.23 | 1,213,749 | 2025-08-11 16:35:58 |
| RPRX | Royalty Pharma plc | RIGGS RORY B | Directior | 2024-01-02 | Sell | 470,000 | 28.13 | 13,222,862 | 2024-01-04 17:16:33 |
| RPRX | Royalty Pharma plc | Avara Management Ltd | 10% Owner | 2023-12-27 | Sell | 251,592 | 28.17 | 7,087,689 | 2023-12-29 16:29:43 |
| RPRX | Royalty Pharma plc | Avara Management Ltd | 10% Owner | 2023-12-15 | Sell | 10,229 | 28.01 | 286,499 | 2023-12-19 16:30:29 |
| RPRX | Royalty Pharma plc | Avara Management Ltd | 10% Owner | 2023-12-13 | Sell | 672,376 | 28.93 | 19,450,288 | 2023-12-15 16:31:02 |
| RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | 2023-08-09 | Sell | 75,000 | 30.73 | 2,305,028 | 2023-08-11 17:00:35 |
| RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | 2023-07-12 | Sell | 75,000 | 31.00 | 2,325,214 | 2023-07-14 18:09:10 |
| RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board 10% Owner | 2023-06-28 | Buy | 130,000 | 29.51 | 3,836,768 | 2023-06-28 16:01:12 |
| RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board 10% Owner | 2023-06-12 | Buy | 90,000 | 32.89 | 2,959,848 | 2023-06-13 16:01:22 |
| RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & CLO | 2023-06-02 | Sell | 192,221 | 33.70 | 6,478,588 | 2023-06-06 17:07:01 |
| RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board 10% Owner | 2023-05-24 | Buy | 150,000 | 32.25 | 4,837,440 | 2023-05-24 18:45:59 |
| RPRX | Royalty Pharma plc | RIGGS RORY B | Directior | 2023-05-22 | Sell | 1,750,000 | 32.82 | 57,435,000 | 2023-05-22 20:36:52 |
| RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board 10% Owner | 2023-05-16 | Buy | 230,000 | 33.38 | 7,676,824 | 2023-05-17 18:41:28 |
| RPRX | Royalty Pharma plc | RIGGS RORY B | Directior | 2023-03-29 | Sell | 139,950 | 36.31 | 5,081,111 | 2023-03-30 17:53:52 |
| RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & CLO | 2023-03-28 | Sell | 112,779 | 37.06 | 4,179,296 | 2023-03-30 17:52:21 |
| RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & CLO | 2023-02-23 | Sell | 25,000 | 37.27 | 931,658 | 2023-02-27 19:14:01 |
| RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | 2023-02-22 | Sell | 23,333 | 37.30 | 870,239 | 2023-02-24 18:26:24 |
| RPRX | Royalty Pharma plc | RIGGS RORY B | Directior | 2022-12-09 | Sell | 60,000 | 42.01 | 2,520,623 | 2022-12-13 18:20:42 |
